-
AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy
- 2023/12/19
- 再生時間: 41 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In this episode, Anthony and Bernie discuss the AML abstracts at ASH that we found most intriguing and controversial!
Abstracts:
- FILO - Stopping Aza/Ven: https://ash.confex.com/ash/2023/webprogram/Paper185437.html
- Revumenib Late Breaking Abstract: https://ash.confex.com/ash/2023/webprogram/Paper192042.html
- JNJ617 Menin Inhibitor Data: https://ash.confex.com/ash/2023/webprogram/Paper172422.html
- SAVE Trial (Revumenib + PO Dec/ven): https://ash.confex.com/ash/2023/webprogram/Paper182337.html
- Dec/Ven vs. 3+7 Randomized Phase II: https://ash.confex.com/ash/2023/webprogram/Paper181347.html
- NCRI AML18 RCT: https://ash.confex.com/ash/2023/webprogram/Paper185956.html
- Impact of NPM1+/FLT3+/MRD in AML17 and AML19: https://ash.confex.com/ash/2023/webprogram/Paper179033.html
- CBF and NPM1 MRD: https://ash.confex.com/ash/2023/webprogram/Paper184848.html
- Persistent MRD by PCR but Flow Negativity in CBF AML (Mast Cell Madness): https://ash.confex.com/ash/2023/webprogram/Paper180275.html
- MORPHO More MRD Analysis: https://ash.confex.com/ash/2023/webprogram/Paper177929.html